FDA is in the pocket of big money interests. Case in point:
FDA is in the pocket of big money interests. Case in point: their actions are what sabotaged Novavax, which should have been the first to market. (FDA yanked their contract manufacturer's plant certification, then recertified it and awarded it to Pfizer. Then, threw all kinds of other stumbling blocks before they finally certified a plant for Novavax -- a plant which was already certified and actively manufacturing. There's more)
Now, after NVAX put all their info in to FDA in mid-January, and has been approved literally everywhere in the world BUT the U.S. -- the FDA says that they will finally get around to reviewing the vaccine in June.
Meanwhile, they put a rush on the Moderna vaccine for kids. Moderna is not being made to wait 6 months before the review meeting. They just submitted the data days ago.
So why would anyone think that the corrupt FDA would be in any hurry to do anything for drugs that work, from SMALL companies?
10
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
SCOR’s Actuarial Awards 2025: A Celebration of Innovation For nearly 30 years, SCOR has consistently honored exemplary research in actuarial science through its prestigious Actuarial Awards. Across six countries, these awards seek to inspire progress in the field, fostering advancements that improve our understanding of risk. Encouraging Research and Excellence The SCOR...
Continue Reading
Gentex Corporation Announces Fourth Quarter Earnings Release Gentex Corporation (NASDAQ: GNTX), a prominent supplier of advanced technology solutions including digital vision and connected car systems, has scheduled the release of its financial results for the fourth quarter and the year-end of 2024. Investors and stakeholders should mark their calendars for January 31,...
Continue Reading
Lockton's Expansion into Saudi Arabia Kansas City, Mo. – Lockton, recognized as the foremost privately held independent insurance brokerage, has embarked on a significant journey by expanding its operations into Saudi Arabia. This strategic move marks an essential development for Lockton, as it enhances its presence in the Middle East and aligns with its overarching...
Continue Reading
Partnership Between AMIAD and Dassault Aviation Leading the Way in Defense Innovation At a recent aerospace gathering, a significant partnership was forged as Pascale Lohat, the Senior Executive VP of Engineering at Dassault Aviation, and Bertrand Rondepierre, Director of the French Agency for AI in Defense (AMIAD), came together to sign a memorandum of understanding....
Continue Reading
Globus Medical, Inc. (NYSE: GMED) made waves in the orthopedic trauma sector back in 2024 with some heavy-hitting product launches. They introduced several groundbreaking systems, including the TENSOR™ Suture Button System—their first foray into suture-based innovations, which snagged 510(k) clearance from the FDA. You know that buzz on the trading floor? It was...
Continue Reading
